Table 3.
Bivariate Analyses and Multivariate Logistic Regression Showing Unadjusted and Adjusted Odds Ratio, Respectively, for the Outcome of Persistent Symptoms, With Moderate–Severe Acute Illness as the Main Exposure; Bolded Values Are Significant With a P Value of <.05
| Variable | Persistent Symptoms OR |
95% CI | Adjusted OR | 95% CI | aOR Limited to >90 Days | 95% CI |
|---|---|---|---|---|---|---|
| Provider-rated moderate–severe dx (265) | 3.68 | 2.14–6.34 | 3.24 | 1.75–6.02 | 3.00 | 1.40–6.41 |
| Hospitalized (278) | 2.31 | 1.12–4.73 | 2.22 | 0.82–6.07 | 2.15 | 0.66–7.02 |
| Age, y | ||||||
| 18–39 | 1 (ref) | 1 | ||||
| 40–59 | 1.89 | 1.11–3.21 | 2.08 | 1.07–4.03 | 2.24 | 1.01–4.95 |
| ≥60 | 1.36 | 0.70–2.65 | 1.80 | 0.77–4.20 | 1.85 | 0.60–5.74 |
| Sex (288) | ||||||
| Male | 1 (ref) | 1 | 1 | |||
| Female | 1.69 | 0.95–2.98 | 1.99 | 0.98–4.04 | 2.73 | 1.10–6.79 |
| Race/ethnicity | — | — | ||||
| White | 1 (ref) | |||||
| Black | 0.82 | 0.49–1.36 | ||||
| Latinx | 0.62 | 0.18–2.13 | ||||
| Asian | 1.40 | 0.43–4.59 | ||||
| Other | 1.68 | 0.49–5.81 | ||||
| Comorbidity (ref: no comorbidity) |
||||||
| Any | 0.99 | 0.60–1.64 | — | |||
| Obesity | 1.06 | 0.66–1.71 | — | |||
| Hypertension | 0.84 | 0.48–1.46 | 0.45 | 0.22–0.94 | 0.33 | 0.13–0.82 |
| Lung disease | 1.61 | 0.86–3.02 | 1.26 | 0.62–2.55 | 1.30 | 0.55–3.08 |
| Heart disease | 1.20 | 0.43–3.34 | 1.29 | 0.39–4.65 | 0.97 | 0.12–7.59 |
| Diabetes | 1.23 | 0.53–2.82 | — | |||
| Cancer | 0.59 | 0.22–1.57 | — | |||
| Immune suppression | 0.96 | 0.45–2.08 | — | |||
| Renal disease | 2.63 | 0.61–11.25 | — | |||
| Annual income | ||||||
| <$30 000 | 0.41 | 0.16–1.02 | — | |||
| $30 000–$60 000 | 0.72 | 0.39–1.35 | — | |||
| $60 000–$100 000 | 1.11 | 0.58–2.15 | ||||
| >$100 000 (ref) | 1 | — |
Abbreviations: aOR, adjusted odds ratio; OR, odds ratio.